FierceBiotech

ESC: Abbott MitraClip study shows gains in functional-yet-leaky heart valves

A study from Abbott found that employing its cardiac valve repair implant during earlier phases of heart failure—when a patient’s leaky mitral valve is still considered to be functional—could lead to ...
TCTMD

Abbott's MitraClip® Treatment Demonstrates Positive Results for Patients with Degenerative Mitral Regurgitation at Prohibitive Risk for Surgery

Results Show Treatment Provides Clinical Benefits and Improves Quality of Life for Patients with Debilitating Mitral Valve Disease Who Are at Prohibitive Surgical Risk ABBOTT PARK, Ill. -- Abbott ...
TCTMD

Abbott's First-In-Class MitraClip® Device Now Available for U.S. Patients

Treatment with Minimally Invasive Device Can Improve Quality of Life for Patients with Debilitating Mitral Valve Disease Who Are at Prohibitive Surgical Risk Abbott Park, Ill. — Abbott today announced ...
Nasdaq

Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand

Abbott Laboratories ABT recently announced FDA approval for its latest version of MitraClip heart valve repair device to treat mitral regurgitation (MR). With the approval for the fourth-generation ...
Star Tribune

Abbott gets boost from strong trial for MitraClip device

Secondary mitral regurgitation (MR) can be a serious complication of heart failure — in a recent study, two-thirds of the people who were taking the maximum recommended doses of drugs for severe forms ...
FiercePharma

Abbott's MitraClip® System Shown to Mend Hearts and Improve Lives in People in the United States

FAVORABLE LATE-BREAKING CLINICAL TRIAL DATA FROM INITIAL COMMERCIAL USE PRESENTED ON TRANSCATHETER MITRAL VALVE REPAIR SYSTEM AT ACC 2015 Vaughn's story shows how MitraClip can help people with a ...
Nasdaq

Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (Revised)

Abbott LaboratoriesABT recently announced favorable results from two distinctly-conducted analyses of the two-year long COAPT (Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy ...
FiercePharma

Data From Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral R

- Positive EVEREST II Results Published in The New England Journal of Medicine and Presented at the American College of Cardiology Conference NEW ORLEANS, April 4, 2011 /PRNewswire/ -- Abbott (NYSE: ...
MD&M East

Abbott Receives 9 Reports of MitraClip’s Delivery System Failing

On February 15, FDA announced that Abbott Vascular has received nine reports of its MitraClip delivery system failing to detach from the Clip, which resulted in the death of one patient and open-heart ...
Business Insider

Landmark Study Shows Treatment with Abbott's MitraClip® is Superior to Medical Therapy for Advanced Heart Failure Patients with Significant Secondary Mitral Regurgitation

SAN DIEGO, Sept. 23, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) today announced positive clinical study results from a randomized controlled trial comparing treatment with the MitraClip ® device to ...
Healthcare Dive

Abbott's MitraClip keeps more heart valve patients alive in study

Abbott Laboratories' MitraClip device for minimally invasive repair of the mitral heart valve in patients with advanced heart failure and severe mitral regurgitation significantly reduced both ...
MD&M East

Abbott Wins Additional Indication for MitraClip

Abbott Laboratories has received an expanded indication for MitraClip. The Abbott Park, IL-based company’s new indication addresses the secondary form of mitral regurgitation and significantly ...